BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31729447)

  • 1. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.
    Wu SC; Lin SF; Fang CW; Tsai IJ; Yang WC
    Sci Rep; 2019 Nov; 9(1):16923. PubMed ID: 31729447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study.
    Chandan JS; Thomas T; Lee S; Marshall T; Willis B; Nirantharakumar K; Gill P
    J Thromb Haemost; 2018 Mar; 16(3):474-480. PubMed ID: 29297977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune thrombocytopenia and risk of stroke: Evidence from a nationwide population-based cohort study.
    Chen HY; Lee WK; Chang R; Hung YM; Hsu CY; Shih YH; Chen JS
    Int J Stroke; 2023 Apr; 18(4):408-415. PubMed ID: 36073612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of immune thrombocytopenia in Taiwan: a nationwide population-based study.
    Hung GY; Lee CY; Yen HJ; Lin LY; Horng JL
    Transfusion; 2018 Nov; 58(11):2712-2719. PubMed ID: 30311951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
    Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
    Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, clinical characteristics, and associated diseases in patients with immune thrombocytopenia: A nationwide population-based study in Taiwan.
    Wu SR; Kuo HC; Huang WC; Huang YF; Chiou YH; Chang YH; Nong BR
    Thromb Res; 2018 Apr; 164():90-95. PubMed ID: 29522912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
    Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
    Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of idiopathic thrombocytopenic purpura correlates with lower rate of acute ST-elevation myocardial infarction.
    Davis M; Movahed MR; Hashemzadeh M; Hashemzadeh M
    Future Cardiol; 2021 Nov; 17(8):1327-1333. PubMed ID: 33988030
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of primary immune thrombocytopenic purpura and atopia among children: a case control study.
    Bahoush G; Poorasgari A; Nojomi M
    Sci Rep; 2020 Jul; 10(1):11717. PubMed ID: 32678199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic thrombocytopenic purpura is strongly associated with higher prevalence of aortic valve disease.
    Haseefa F; Movahed MR; Hashemzadeh M; Hashemzadeh M
    Ann Hematol; 2020 Sep; 99(9):2081-2084. PubMed ID: 32691113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
    Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
    Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review.
    Abrahamson PE; Hall SA; Feudjo-Tepie M; Mitrani-Gold FS; Logie J
    Eur J Haematol; 2009 Aug; 83(2):83-9. PubMed ID: 19245532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.
    Lai SW; Lin HF; Lin CL; Liao KF
    Intern Emerg Med; 2017 Mar; 12(2):157-162. PubMed ID: 27562379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study.
    Ekstrand C; Bahmanyar S; Cherif H; Kieler H; Linder M
    Cancer Epidemiol; 2020 Dec; 69():101806. PubMed ID: 32947155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.
    Doobaree IU; Nandigam R; Bennett D; Newland A; Provan D
    Eur J Haematol; 2016 Oct; 97(4):321-30. PubMed ID: 27199203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
    Chrobák L
    Vnitr Lek; 2002 Aug; 48(8):773-80. PubMed ID: 12425210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction.
    Davis M; Movahed MR; Hashemzadeh M; Hashemzadeh M
    Ann Hematol; 2022 Jan; 101(1):21-26. PubMed ID: 34596718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease burden of immune thrombocytopenic purpura among adult patients: the analysis of Thailand healthcare databases 2010.
    Teawtrakul N; Sirijerachai C; Chansung K; Wanitpongpun C; Sutra S
    J Med Assoc Thai; 2012 Jul; 95 Suppl 7():S217-23. PubMed ID: 23130458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.
    An R; Wang PP
    Vasc Health Risk Manag; 2017; 13():15-21. PubMed ID: 28176930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.